Molbio Diagnostics IPO Allotment Date
As per the timeline, the Molbio Diagnostics IPO allotment date is August 13, 2026, Thursday. The investors can check the IPO allotment via the registrar website of KfinTech or the BSE, NSE website. Investors can check the allotment status online and offline with easy steps given below:
Molbio Diagnostics IPO Allotment Links
| Registrar: | KfinTech IPO Allotment Page |
| BSE: | BSE IPO Allotment Page |
| NSE: | NSE IPO Allotment Page |
| IPO Watch: | IPO Allotment Status Page |
Check Molbio Diagnostics’ IPO Allotment Status on Registrar site?
- Visit Kfin Technologies Ltd. website
- Select IPO Name ‘Molbio Diagnostics’ from the drop-down menu on the page
- Enter details required like PAN Card, Application Number, or Demat Account Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
Check Molbio Diagnostics IPO Allotment Status on BSE?
- Visit BSE India IPO Allotment Page
- Select the issue type: equity/debt
- Select IPO Name ‘Molbio Diagnostics’ from the drop-down menu on the page
- Enter details required like PAN Card or Application Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
Check Molbio Diagnostics IPO Allotment Status on NSE?
- Visit NSE India IPO Allotment Page
- Select the issue type
- Select IPO Name ‘Molbio Diagnostics’ from the drop-down menu on the page
- Enter details required like PAN Card or Application Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
IPO Subscription Details
| Category | Day 1 | Day 2 | Day 3 |
| QIB | 1.00 | 1.39 | 186.39 |
| NII | 0.73 | 4.46 | 49.80 |
| bNII | 0.70 | 4.31 | 50.82 |
| sNII | 0.80 | 7.02 | 47.76 |
| RII | 0.77 | 3.19 | 12.97 |
| EMP | 2.12 | 4.79 | 13.28 |
| Total | 0.83 | 2.95 | 70.27 |
Molbio Diagnostics IPO Key Dates
| IPO Open Date: | August 10, 2026 |
| IPO Close Date: | August 12, 2026 |
| Basis of Allotment: | August 13, 2026 |
| Refunds: | August 14, 2026 |
| Credit to Demat Account: | August 14, 2026 |
| IPO Listing Date: | August 17, 2026 |
Business Overview
Molbio Diagnostics is an innovative point-of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results within an hour. Designed for use in resource-limited settings, it enables quick and decentralised disease diagnosis at the point of care.
Through its wholly owned subsidiary, Bigtec Labs, Molbio has strong research and development capabilities focused on creating diagnostic platforms for point-of-care (POC) testing. From product development to large-scale deployment, the company aims to improve access to reliable and affordable healthcare for everyone.
Note for the Investors
Molbio Diagnostics IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Molbio Diagnostics IPO Allotment date and time please contact the registrar with your queries.
